North America Aquatic Veterinary Market Size and Forecast (2021 - 2031)

The North America Aquatic Veterinary Market is projected to grow significantly, reaching an estimated US$ 780.3 million by 2031, up from US$ 594.6 million in 2024. This growth represents a compound annual growth rate (CAGR) of 4.0% from 2025 to 2031, driven by the expanding aquaculture industry and increasing demand for seafood and aquatic animal products.

Executive Summary and Market Analysis

The North American aquatic veterinary market encompasses the United States, Canada, and Mexico, with the United States holding the largest share. The rapid growth in this sector is largely attributed to the booming aquaculture industry, which is responding to the rising consumer demand for seafood. As fish farming operations expand, the need for specialized veterinary services is also increasing. These services include disease prevention, health monitoring, and biosecurity management, all of which are crucial for maintaining healthy fish stocks and preventing disease outbreaks.

The United States is a key player in this market, particularly in freshwater aquaculture. States like Mississippi are at the forefront of catfish production, relying heavily on veterinary expertise to ensure the health of fish populations and to mitigate disease risks. Canada also plays a significant role, with a well-established aquaculture sector that emphasizes sustainable fish production practices. Together, these factors contribute to a robust and steadily growing market for aquatic veterinary care across North America.

Strategic Insights

Market Segmentation Analysis

The North America Aquatic Veterinary Market can be segmented in several ways:

• By Type: The market is divided into Diagnostic and Treatment segments, with the Treatment segment leading in 2024.
• By Diagnostic Type: This includes Serological, Molecular Diagnosis, DNA Sequencing, and Other Diagnostics, where Molecular Diagnosis was the dominant segment in 2024.
• By Treatment Type: The Treatment segment is further divided into Vaccines, Medications, and Supplements, with Medications being the leading category.
• By Species: The market is segmented into Fish, Crustaceans, Mollusca, and Others, with Fish being the predominant species in 2024.
• By Disease Source: This includes Bacterial, Viral, Parasites, and Others, with Bacterial diseases being the most significant segment.
• By Route of Administration: The market is segmented into Water Medication, Medicated Feed, and Other Routes, with Water Medication leading the way in 2024.

Market Outlook

Government initiatives and support from non-profit organizations are crucial in enhancing aquatic veterinary medicine, particularly in response to the growing demand driven by aquaculture expansion and disease management challenges. These initiatives focus on funding research, improving diagnostic infrastructure, establishing regulatory frameworks, and building capacity among veterinarians. For example, the U.S. Food and Drug Administration (FDA) launched the Center for Veterinary Medicine Aquaculture Strategic Plan (2022-2026), which prioritizes drug approvals and antimicrobial stewardship, providing veterinarians with effective tools to combat aquatic diseases.

Additionally, the U.S. Omnibus Bill of 2022 allocated US$5 million to the USDA's Aquatic Animal Health Program, aimed at enhancing biosecurity, surveillance, and farmer education under the National Aquaculture Health Plan. These efforts directly support veterinarians by providing resources for disease prevention and management, thereby propelling market growth.

Country Insights

The North American Aquatic Veterinary Market is primarily segmented by country into the United States, Canada, and Mexico, with the United States holding the largest market share in 2024. According to the National Oceanic and Atmospheric Administration (NOAA), approximately 75-90% of seafood consumed in the U.S. is imported. From 1990 to 2022, per capita seafood consumption in the U.S. increased by 38%, reaching 20.8 pounds per person in 2022. This rising demand for seafood necessitates veterinary products such as vaccines, diagnostics, and therapeutics to manage health in intensive farming systems, where high stocking densities increase disease risks.

In August 2025, U.S. Senators introduced a bipartisan bill aimed at promoting commercial-scale open-ocean aquaculture. This legislation seeks to streamline the permitting process, fund research on sustainable practices, and address disease management in offshore farms. By expanding U.S. aquaculture for species like cobia and red snapper, the bill is expected to increase the demand for veterinary products to prevent outbreaks in these new environments, aligning with NOAA's goals for resilient seafood production.

Company Profiles

Key players in the North America Aquatic Veterinary Market include Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Virbac SA, Phibro Animal Health Corp, HIPRA SA, Indian Immunologicals Ltd, Esox Biologics Ltd, Ceva Polchem Pvt Ltd, and Aquatic Diagnostics Ltd. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

In conclusion, the North America Aquatic Veterinary Market is poised for significant growth, driven by the expanding aquaculture industry, increasing seafood demand, and supportive government initiatives aimed at improving veterinary services and disease management.